A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

This finding reinforces PROSTOX as a true measure of the biological response to radiation, independent of treatment era or technique, that can identify the safest course of [prostate cancer ...

(HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers ... toxicity in patients with prostate cancer, according to a study published online April 7 in Clinical ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

The breakthrough blood test uses AI to detect the 12 most lethal and common cancers from an mRNA signature which shows if ...

Early detection of colon cancer can prevent a majority of deaths, possibly as much as nine in 10 of them. Yet only about 69% ...

Patients could soon benefit from world-leading technology to diagnose bowel cancer earlier, faster, and cheaper, reducing the ne ...

Breakthrough in bowel cancer research will speed up diagnosis: United Kingdom Friday, April 25, 2025, 16:00 Hrs [IST] Patients could soon benefit from world-leading technology to ...

Research suggests the test, known as miONCO-Dx, can detect 12 cancers at an early stage with 99% accuracy. However, a larger ...

7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy ... copy of a gene called a microRNA (miRNA) enabled ...

As part of the Plan for Change, the UK Government is prioritising cancer care to improve the NHS, including reducing waiting ...